![](/img/cover-not-exists.png)
LBA39IMmotion150: Novel radiological endpoints and updated data from a randomized phase II trial investigating atezolizumab (atezo) with or without bevacizumab (bev) vs sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC)
Powles, T., McDermott, D.F., Rini, B., Motzer, R.J., Atkins, M.B., Fong, L., Joseph, R.W., Pal, S.K., Ravaud, A., Bracarda, S., Rodriguez, C. Suarez, Maio, M., Gore, M., Grünwald, V., Staehler, M., QiVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx440.033
Date:
September, 2017
File:
PDF, 67 KB
english, 2017